RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.
Registered Office
Via Matteo Civitali, 1 20148 Milano, Italy Tel. +39 02 487871 Fax +39 02 40073747
www.recordati.com
Share Capital € 26.140.644,50 fully paid -up Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150 Tax Code/VAT No. 00748210150 Milano R.E.A. No. 401832 Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l
NEWS RELEASE
RECORDATI : PUBLICATION OF THE INTERIM REPORT FIRST HALF (AS AT 30.06.202 6)
Milan, 30th July 2026 – Please be informed that the Interim Report First Half as at 30th June 202 6, approved on 2 8th July 202 6 by the Board of Directors, as per the press release issued on the same date, to which reference is made, is available to the public, together with the Independent Auditors’ Report on the interim consolidated financial statements as at 30th June 202 6, as of today, at the Company’s registered office, on the Company’s website and on the “ 1INFO ” storage mechanism.
Recordati is an international pharmaceutical Group listed on the Italian Stock Exchange (XMIL: REC), with roots dating back to a family -run pharmacy in Northern Italy in the 1920s. We are uniquely structured to provide treatments across specialty and primary care and rare diseases. Our fully integrated op erations span clinical development, manufacturing of active ingredients and finished products, commerciali zation and licensing. We operate in approximately 150 countries across EMEA, the Americas and APAC , with around 4,700 employees. We believe that health is a fundamental right, not a privilege. Today, our purpose “Unlocking the full potential of life” aims to empower individuals to live life to the fullest, from common conditions to the rarest.
Investor Relations
Eugenia Litz
Eugenia.Litz@recordati.com
Gianluca Saletta
saletta.g@recordati.it
Media Relations
Laura Conti
conti.l@recordati.it Rebecca Kerr
rebecca.kerr@recordati.com
.